Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ensifentrine + Tiotropium in COPD
NCT03028142Phase 2Completed
- Sponsor
- Verona Pharma
- Start
- Jan 2017
- Primary completion
- Aug 2017
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of ensifentrine in chronic obstructive pulmonary disease (COPD), sponsored by Verona Pharma. Started Jan 2017; status: completed.
02
Drugs
ensifentrine
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT03028142.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03028142.